Inflammation in the body is beneficial, but too much of a good thing can be bad. Especially when excess, unregulated inflammation in the intestines leads to chronic diarrhea caused by a condition ...

The phone rings. It’s a call we get a dozen times a day. “My dog has diarrhea.” Or vomiting. Or, most often, both. It’s the bread and butter of small animal practice. So common, in fact, that it’s ...

“Specifically, our objective is to partner with an animal health company to achieve three parallel goals for Canalevia: Expand the U.S. indication from CID in dogs to treatment of general diarrhea in ...

Jaguar Health, Inc. (Jaguar) is a commercial stage pharmaceuticals company focused on developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for ...

SAN FRANCISCO, CA / ACCESS Newswire / August 21, 2025 / Jaguar Health, Inc. (NASDAQ:JAGX) (“Jaguar”), under its Jaguar Animal Health tradename for the veterinary market, today announced it is ...

Canalevia ® (crofelemer delayed-release tablets), under the name Canalevia ®-CA1, is conditionally approved by the FDA for treatment of CID in dogs Company strategy: In discussions with multiple ...